Several mechanisms contributing to aldosterone/MR activation-induced glucose intolerance and insulin resistance have been indicated, including impaired pancreatic beta cell function and related increases in hepatic gluconeogenesis. The gene discussed is NR3C2; the disease is Insulin resistance.